AbstractTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021Rifampin Urine Colorimetry for Evaluation of Tuberculosis PharmacokineticsView Abstract
AbstractTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021Pravastatin pharmacokinetics when administered simultaneously with first-line tuberculosis treatmentView Abstract
AbstractTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021Population Pharmacokinetic Modeling of Pretomanid Dispersible-Tablet Formulation in Healthy VolunteersView Abstract
AbstractTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021Population pharmacokinetics of cycloserine, administered as terizidone, in South African children treated for rifampicin-resistant tuberculosis.View Abstract
AbstractTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021PLASMA BEDAQUILINE LEVELS IN INDIAN MDR-TB PATIENTSView Abstract
AbstractTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021Pharmacokinetics of Rifampicin in Plasma, Cerebrospinal Fluid, and Brain Extracellular Fluid in South African ChildrenView Abstract
AbstractTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021Pharmacokinetics of linezolid in Indian patients with multidrug-resistant tuberculosisView Abstract
AbstractTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021Pentamidine shows promising activity against M. tuberculosis and M. avium complex but not M. abscessusView Abstract
AbstractTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021Optimized loading period strategies for bedaquiline at the restart of drug-resistant tuberculosis treatmentView Abstract
AbstractTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021Operational Challenges with Centralising PK Bioanalysis in a Multicentre Multinational Randomised Controlled TrialView Abstract
AbstractTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021Investigating the treatment shorting potential of sutezolid-containing regimens in a murine model with confirmed drug exposuresView Abstract
AbstractTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021Exposure-response relationship for bedaquiline, delamanid, and their metabolitesView Abstract
